Title:
LIQUID PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2023/224112
Kind Code:
A1
Abstract:
The present disclosure addresses at least the following problem. Specifically, the present disclosure addresses the problem of providing a technology that makes it possible to obtain high physiological activity when a liquid pharmaceutical composition containing an in-vivo-functional substance that exhibits physiological activity in a subject to whom the composition is injected. This problem is solved by a liquid pharmaceutical composition that contains an in-vivo-functional substance, that demonstrates an osmotic pressure greater than 400 mOsmol/kg but no greater than 1,000 mOsmol/kg, and that is injected into a subject by an injector for injecting a liquid pharmaceutical composition into a subject without the use of an injection needle.
Inventors:
SAKAGUCHI NAOKI (JP)
Application Number:
PCT/JP2023/018700
Publication Date:
November 23, 2023
Filing Date:
May 19, 2023
Export Citation:
Assignee:
DAICEL CORP (JP)
International Classes:
A61K9/08; A61K31/7088; A61K45/00; A61K47/02; A61K47/26; A61K48/00; A61M5/303; A61P43/00
Domestic Patent References:
| WO2019156237A1 | 2019-08-15 |
Foreign References:
| JP2020146056A | 2020-09-17 | |||
| JP2019514998A | 2019-06-06 | |||
| JP2022062014A | 2022-04-19 | |||
| JP2005527538A | 2005-09-15 | |||
| JP2019532927A | 2019-11-14 |
Attorney, Agent or Firm:
IP FIRM SHUWA (JP)
Download PDF:
Previous Patent: CELL-ADHESIVE COMPOSITION AND POLYMER-COATED MICROPARTICLES
Next Patent: SEMICONDUCTOR DEVICE
Next Patent: SEMICONDUCTOR DEVICE